Another medical breakthrough is shaking the world, and this time, it’s good news. Check out the latest discoveries regarding diabetes treatment below.
New diabetes treatment
It’s been revealed that the US approval of a drug that can delay the onset of type 1 diabetes represents the “start of a seismic shift” in treating the condition, a British charity has said.
According to the official reports, “Teplizumab is a type of immunotherapy that works by tackling the root cause of diabetes rather than just its symptoms. The drug tells the immune system not to attack pancreatic cells which produce insulin. These are vital for controlling blood glucose levels.”
It’s also extremely important to note the fact that in type 1 diabetes, the pancreas no longer makes insulin, so people have to inject it to keep their blood sugar levels steady.
Today’s landmark approval of teplizumab in the US is the start of a seismic shift in how type 1 diabetes is treated.
Conclusions about the treatment
It’s also important to mention the fact that if left untreated, type 1 diabetes is life-threatening.
Chris Askew, chief executive of Diabetes UK, said: “Today’s landmark approval of teplizumab in the US is the start of a seismic shift in how type 1 diabetes is treated.
“For 100 years, people living with type 1 diabetes have relied on insulin to treat the condition, and today’s decision means that for the first time, the root cause of the condition – an immune system attack – can be tackled and type 1 diabetes potentially delayed for up to three years.”
???? BREAKING NEWS: The world’s first ever immunotherapy for #Type1Diabetes has been approved in the US.
It’s the biggest breakthrough for the condition since the discovery of insulin 100 years ago. Read more about this milestone moment in T1 history: https://t.co/EvGd5IILnR (1/3) pic.twitter.com/hrm2iUryw7
— Diabetes UK (@DiabetesUK) November 17, 2022
The expert also said the following:
“The licensing of teplizumab in the UK must now be accelerated, and we’re working with the NHS and with other diabetes charities and key stakeholders to ensure that people in the UK can benefit from this life-changing treatment as soon as possible.”
